Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any oculomotor apraxia or related oculomotor disease in which the cause of the disease is a mutation in the PNKP gene.
Features include always present findings: Shrinkage of the cerebellum (cerebellar atrophy), Areflexia, Ataxia, and Oculomotor apraxia and others; and common findings: Dystonia, Hypercholesterolemia, Impaired vibratory sensation, and Hypoalbuminemia and others. 15 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 5 | Dystonia, Ataxia, Difficulty with thinking and memory (cognitive impairment) |
PNKP function has not been fully characterized.
Ataxia - oculomotor apraxia type 4 is associated with mutations in the PNKP gene on chromosome 19.
Genetic testing for PNKP is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for ataxia - oculomotor apraxia type 4 has been reported in the published literature.
Phenotype severity distribution: 5 always present features, 7 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for ataxia - oculomotor apraxia type 4.
218 publications have been identified in PubMed for ataxia - oculomotor apraxia type 4. Research spans Case Report / Case Series (33%), Review / Meta-Analysis (19%), and Basic Science / Preclinical (16%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 73 | 33% |
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 10:48 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Muscles | 2 | Shrinkage of the cerebellum (cerebellar atrophy), Atrophy/Degeneration affecting the brainstem |
Lab test results | 1 | Elevated circulating alpha-fetoprotein concentration |
Eyes | 1 | Oculomotor apraxia |
Research summaries
41 |
19% |
Laboratory research | 35 | 16% |
Clinical study results | 26 | 12% |
Disease patterns and progression | 21 | 10% |
Testing and diagnosis research | 16 | 7% |
New treatment approaches | 4 | 2% |
Other research | 2 | 1% |
Yakubovsky M (2026). [PMID: 41580648](https://pubmed.ncbi.nlm.nih.gov/41580648/). *BMC infectious diseases*. [Case Report / Case Series]
Charoenrook V (2026). [PMID: 41683752](https://pubmed.ncbi.nlm.nih.gov/41683752/). *Int J Mol Sci*. [Clinical Trial Publication]
Bowers E (2026). [PMID: 35593853](https://pubmed.ncbi.nlm.nih.gov/35593853/). *Unknown Journal*. [Basic Science / Preclinical]
Popov T (2026). [PMID: 42015609](https://pubmed.ncbi.nlm.nih.gov/42015609/). *Psychophysiology*. [Review / Meta-Analysis]
Martínez-Flores R (2026). [PMID: 42039626](https://pubmed.ncbi.nlm.nih.gov/42039626/). *bioRxiv*. [Diagnostic / Biomarker]
Baigrie D (2026). [PMID: 29489227](https://pubmed.ncbi.nlm.nih.gov/29489227/). *Unknown Journal*. [Clinical Trial Publication]
Oubre B (2026). [PMID: 40964858](https://pubmed.ncbi.nlm.nih.gov/40964858/). *Annals of neurology*. [Diagnostic / Biomarker]
Leng Y (2026). [PMID: 42079593](https://pubmed.ncbi.nlm.nih.gov/42079593/). *Front Immunol*. [Epidemiology / Natural History]
Medina JA (2026). [PMID: 42133109](https://pubmed.ncbi.nlm.nih.gov/42133109/). *Childs Nerv Syst*. [Review / Meta-Analysis]
Mendes J (2026). [PMID: 42039758](https://pubmed.ncbi.nlm.nih.gov/42039758/). *Case Rep Ophthalmol*. [Case Report / Case Series]